A rare disease veteran, Inozyme’s new CEO sharpens the company’s focus

3 years ago

by David Miller

948 Views

After taking the reins from the company’s founding CEO, Douglas Treco is guiding Inozyme through the clinic.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller